Correlation of rat cortical Fas-associated death domain (FADD) protein phosphorylation with the severity of spontaneous morphine abstinence syndrome: Role of α 2-adrenoceptors and extracellular signal-regulated kinases

Journal of Psychopharmacology

Volumn 25, Issue 12, 2011, Pages 1691-1702

  Ramos Miguel, Alfredo ^a   Miralles, Antonio ^a   García Sevilla, Jesús A ^a  

^a IUNICS   (Spain)

Author keywords

2 adrenoceptors; Akt1 kinase; FADD phosphorylation; MAP kinases; morphine spontaneous withdrawal; opiate addiction; PEA 15; rat brain

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CEREBRAL CORTEX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHINE DEPENDENCE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 80054011570     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110387842     Document Type: Article

References (44)

1. Aghajanian GK. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 1978 ; 276: 186-188 (Pubitemid 9068251)
2. Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE, et al. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell. 2005 ; 19: 321-332 (Pubitemid 41074888)
3. Alexander SPH, Mathie A, Peters JA. Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol. 2009 ; 158 (Suppl 1). S1 - S254
4. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol. 2002 ; 22: 207-220 (Pubitemid 33144269)
5. Almela P, Milanés MV, Laorden ML. Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal. Br J Pharmacol. 2007 ; 151: 787-797 (Pubitemid 47075329)
6. Bläsig J, Herz A, Reinhold K, Zieglgänsberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology (Berl). 1973 ; 33: 19-28
7. Bramham CR, Worley PF, Moore MJ, Guzowski JF. The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci. 2008 ; 28: 11760-11767
8. Brami-Cherrier K, Roze E, Girault J-A, Betuing S, Caboche J. Role of the ERK/MSK1 signaling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem. 2009 ; 108: 1323-1335
9. 2a-adrenoceptor mRNA in brain. Mol Brain Res. 1997 ; 45: 154-158 (Pubitemid 27182238)
10. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995 ; 81: 505-512
11. Christie MJ. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008 ; 154: 384-396 (Pubitemid 351670590)
12. Daglish MR, Weinstein A, Malizia AL, Wilson S, Melichar JK, Lingford-Hughes A, et al. Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"?. Neuroimage. 2003 ; 20: 1964-1970 (Pubitemid 37543614)
13. Edwards S, Graham DL, Whisler KN, Self DW. Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration. Synapse. 2009 ; 63: 224-235
14. Ferrer-Alcón M, García-Fuster MJ, La Harpe R, García-Sevilla JA. Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts. J Neurochem. 2004 ; 90: 220-230 (Pubitemid 38879176)
15. 2-adrenoceptors in the rat brain: Up-regulation of receptors associated with increased receptor appearance. J Neurochem. 1995 ; 64: 2590-2597
16. García-Sevilla JA, García-Fuster MJ. Acute and chronic antidepressants downregulate FADD in rat brain: involvement of monoamine receptors. Eur Neuropsychopharmacol. 2009 ; 19 (Suppl 3). S431
17. García-Fuster MJ, Clinton SM, Watson SJ, Akil H. Effect of cocaine on Fas-associated protein with death domain in the rat brain: Individual differences in a model of differential vulnerability to drug abuse. Neuropsychopharmacology. 2009 ; 34: 1123-1134
18. García-Fuster MJ, Miralles A, García-Sevilla JA. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspasas in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychophamacology. 2007 ; 32: 399-411 (Pubitemid 46106946)
19. García-Fuster MJ, Ramos-Miguel A, Miralles A, García- Sevilla JA. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (p-Ser191/194 FADD) protein in the rat brain: functional interactions with casein kinase Iα, Gαi proteins, and ERK1/2 signaling. Neuropharmacology. 2008a ; 55: 886-899
20. García-Fuster MJ, Ramos-Miguel A, Rivero G, La Harpe R, Meana JJ, García-Sevilla JA. Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers. Neuroscience. 2008b ; 157: 105-119
21. Gellert VF, Holtzman SG. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking soluctions. J Pharmacol Exp Ther. 1978 ; 205: 536-546 (Pubitemid 8393075)
22. Hua ZC, Sohn SJ, Kang C, Cado D, Winoto A. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity. 2003 ; 18: 513-521 (Pubitemid 36513633)
23. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci. 2006 ; 29: 565-598 (Pubitemid 44476856)
24. Kalivas PW, O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology. 2008 ; 33: 166-180 (Pubitemid 350191316)
25. Le Moal M, Koob GF. Drug addiction: Pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol. 2007 ; 17: 377-393 (Pubitemid 46497657)
26. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: Biochemical and pharmacological evidence. Neurosci Biobehav Rev. 1997 ; 21: 91-104 (Pubitemid 27044553)
27. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ. DeltaFosB: a molecular switch for long-term adaptation in the brain. Mol Brain Res. 2004 ; 132: 146-154 (Pubitemid 39586757)
28. Meller E, Goldstein M, Friedhorff AJ, Schweitzer JW. N-Ethoxycarbonyl-2- ethoxy-1,2-dihydroquinoline (EEDQ): a new tool to probe CNS receptor function. Adv Exp Med Biol. 1988 ; 235: 121-136
29. 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo. J Neurochem. 1993 ; 61: 1602-1610 (Pubitemid 23317179)
30. Moulédous L, Díaz MF, Gutstein HB. Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouse. Pharmacol Biochem Behav. 2007 ; 88: 39-46 (Pubitemid 47379821)
31. 2A-adrenoceptor as revealed by a sequence-specific antibody. Neurosci Lett. 1999 ; 262: 105-108 (Pubitemid 29158939)
32. Ozaita A, Escribá PV, Ventayol P, Murga C, Mayor F, García-Sevilla JA. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J Neurochem. 1998 ; 70: 1249-1257 (Pubitemid 28113661)
33. Ramos-Miguel A, Esteban S, García-Sevilla JA. The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity. Eur Neuropsychopharmacol. 2010 ; 20: 49-64
34. Ramos-Miguel A, García-Fuster MJ, Callado LF, La Harpe R, Meana JJ, García-Sevilla JA. Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity. Neuroscience. 2009 ; 161: 23-38
35. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J. 2005 ; 390: 729-735 (Pubitemid 41395356)
36. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, et al. Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci. 2009 ; 29: 3529-3537
37. Salvesen GS, Riedl SJ. Structure of the Fas/FADD complex. Cell Cycle. 2009 ; 17: 2723-2727
38. Scaffidi C, Volkland J, Blomberg I, Hoffmann I, Krammer PH, Peter ME. Phosphorylation of FADD/MORT I at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J Immunol. 2000 ; 164: 1236-1242 (Pubitemid 30067235)
39. Selcher JC, Atkins CM, Trzaskos JM, Paylor R, Sweatt JD. A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem. 1999 ; 6: 478-490 (Pubitemid 29503844)
40. 2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn-Schmiedegergs Arch Pharmacol. 1987 ; 336: 530-537 (Pubitemid 17166842)
41. Valmiki MG, Ramos JW. Death effector domain-containing proteins. Cell Mol Life Sci. 2009 ; 66: 814-830
42. Williams TM, Daglish MRC, Lingford-Hughes A, Taylor LG, Hammers A, Brooks DJ, et al. Brain opioid receptor binding in early abstinence from opioid dependence. Br J Psychiatry. 2007 ; 191: 63-69 (Pubitemid 47035183)
43. Zhai H, Li Y, Wang X, Lu L. Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement. Cell Mol Neurobiol. 2008 ; 28: 157-172
44. Zhang J, Zhang D, Hua Z. FADD and its phosphorylation. IUBMB Life. 2004 ; 56: 395-401 (Pubitemid 39564303)